194 SolovyevN.DrobyshevE.BjrklundG.DubrovskiiY.LysiukR.RaymanM
The fast-changing landscape, which includes the expected entry of new drugs and generic competition, has led to a recalculation of what the peak will be and when those heights may be reached, analysts and investors say
Thats why the FDAs own technical staff has recommended against expanded access, and the public health group Partnership for Safe Medicines calls them "popular, unproven, dangerous. As Peter Kolchinsky, managing partner of biotech investor RA Capital Management, puts it: Is the FDA going to stand on science or is it going to permit all kinds of snake oil to be readily available? The FDA meeting will last two days
The cost for 21 capsules of Ibrance is over $15,000
The idea behind pairing the two is that they work on different problems
With over 16 years of experience, physicians often witness their patients navigate the full spectrum of health challenges as they age, including the increased risk of heart disease